Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2011-07-21

Clinical Trial Update: Ibuprofen vs. Continuous Indomethacin in the Treatment of PDA [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ibuprofen with continuous indomethacin for patent ductus arteriosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INDOMETHACIN (INDOMETHACIN)
  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Shaare Zedek Medical Center | Conditions: Patent Ductus Arteriosus | Phase 3 | Status: COMPLETED